Conversion by Stultz Katherine V of 8126 shares of Graphite Bio
GRPHDelisted Stock | USD 2.67 0.05 1.84% |
Under 62% of Graphite Bio's investor base is looking to short. The analysis of current outlook of investing in Graphite Bio suggests that many traders are alarmed regarding Graphite Bio's prospects. Graphite Bio's investing sentiment shows overall attitude of investors towards Graphite Bio.
Graphite |
Filed transaction by Graphite Bio Inc officer. Derivative codes conversion of derivative security
Read at macroaxis.com
Graphite Bio Fundamental Analysis
We analyze Graphite Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Graphite Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Graphite Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Graphite Bio is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Graphite Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Graphite Bio stock to make a market-neutral strategy. Peer analysis of Graphite Bio could also be used in its relative valuation, which is a method of valuing Graphite Bio by comparing valuation metrics with similar companies.
Peers
Graphite Bio Related Equities
SNSE | Sensei Biotherapeutics | 8.33 | ||||
TIL | Instil Bio | 5.61 | ||||
NUVB | Nuvation Bio | 3.70 | ||||
CTMX | CytomX Therapeutics | 2.30 | ||||
ASMB | Assembly Biosciences | 2.17 | ||||
ACHL | Achilles Therapeutics | 0.93 | ||||
NXTC | NextCure | 7.75 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |